Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02263508
Brief Title: Pembrolizumab With or Without Talimogene Laherparepvec or Talimogene Laherparepvec Placebo in Unresected Melanoma (KEYNOTE-034)

First Submitted : September 26, 2014
First Submitted that Met QC Criteria : October 9, 2014
First Posted : October 13, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : December 18, 2018
Last Update Posted : December 19, 2018